We conducted a prospective study over 24 months to compare health-rela
ted quality of life in surgically and medically treated patients with
intractable temporal lobe epilepsy. Seizure frequency and health-relat
ed quality of life were assessed in 81 patients before and 6, 12, and
24 months after treatment. Using the Epilepsy Surgery Inventory 55 (ES
I-55), we compared (1) different seizure outcome groups and (2) tempor
al lobectomy with continuing medical management. Follow-up was satisfa
ctory in 72 patients (89%), 51 treated with temporal lobectomy and 21
with no surgery. Pretreatment seizures and health-related quality of l
ife were comparable in the two groups. Seizure outcome was significant
ly better at 6, 12, and 24 months after surgery. At 24 months, seizure
-free patients and those with at least a 90% reduction in seizure freq
uency reported significant improvements in health-related quality of l
ife (on 5 of 10 subscales and overall Epilepsy Surgery Inventory 55 sc
ale). Deterioration in quality of life occurred with less than 90% sei
zure reduction. Only one Epilepsy Surgery Inventory 55 subscale at 6 m
onths and two subscales at 12 months showed a significant difference.
Patients with good seizure outcome experience improved health-related
quality of life after treatment. Since temporal lobectomy results in c
onsiderably better seizure control than continued medical management,
the findings support surgery as the preferred treatment, although chan
ges in health-related quality of life may not be evident until the sec
ond postoperative year.